Abcellute

About:

Abcellute provides non-cryogenic cell preservation technology for the preservation and storage of fresh primary liver cells.

Website: http://www.abcellute.com

Top Investors: Development Bank of Wales, Fusion IP

Description:

Abcellute is to achieve global adoption of its SureCellâ„¢ cell transport technology by providing the research community with enhanced, fresh-cell systems. These will maximise the utilisation of this often scarce resource and provide products that are much more convenient to use than current fresh-cell systems. This will deliver benefits to biomedical researchers in key areas such as pre-clinical drug evaluation and regenerative medicine.